Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,765 total articles
Inuvo, Inc., a US-based AI-driven advertising technology company, announced the hiring of key leadership personnel to strengthen its growth strategy, programmatic operations, and branding efforts for its IntentKey AI media platform. These new appointments aim to integrate business development, media execution, and market positioning to accelerate c…
Adeia Inc., a Nasdaq-listed technology company specializing in foundational media and semiconductor IP, announced the renewal of its multi-year intellectual property license agreement with Google. The agreement allows Google continued broad access to Adeia's extensive media IP portfolio, reinforcing their long-term relationship and supporting Googl…
EXL, a global data and AI company listed on NASDAQ as EXLS, appointed Bhupender Singh as President and Head of International Growth Markets to lead expansion in EMEA and APAC regions. Singh brings over 25 years of senior leadership experience and will focus on accelerating growth, uniting cross-cultural teams, and establishing EXL as a premier data…
TON Strategy Company announced their Q1 2026 financial results showing $5.3 million revenue, including $3.0 million from staking Toncoin, though reporting an overall net loss driven by unrealized asset depreciation. They hold approximately 222 million Toncoin tokens representing 4.29% of all Toncoin, with significant staking usage in the network. R…
Lyell Immunopharma announced that senior management will participate in two key investor conferences in May 2026 to discuss the company's pipeline of next-generation CAR T-cell therapies. The company highlights its capacity for commercial manufacturing and plans to provide live webcasts of the presentations.
Gelteq Limited announced a strategic debt financing round worth up to $3.5 million aimed at accelerating commercialization efforts, expanding clinical trial activity, and supporting revenue growth. The funds will be used to scale clinical programs and ramp up sales across key markets, enhancing operational scalability and market adoption of its pro…
Incannex Healthcare Inc., a Nasdaq-listed biopharmaceutical company, announced it has won the 'Best New Technology Solution for Drug Development' award at the MedTech Breakthrough Awards for its lead drug candidate IHL-42X. This oral fixed-dose combination therapy targets obstructive sleep apnea and has shown positive Phase 2 clinical results. The …
AtaiBeckley Inc., a clinical-stage biotech company focused on mental health treatments, reported Q1 2026 financial results and updates on its clinical programs. The company is on track to start its pivotal Phase 3 trial for BPL-003 in treatment-resistant depression in Q2 2026 and anticipates Phase 2 results for VLS-01 later this year. EMP-01 Phase …
Aptera Motors has successfully completed assembly of its first five validation vehicles at its Carlsbad, California facility, marking a key milestone in its transition from development to production. The low-volume validation assembly line allows continuous improvement of manufacturing processes, supporting the company's mission to deliver ultra-ef…
FactSet has announced a partnership with valuation technology provider Valutico to create an integrated and scalable valuation workflow tailored for private capital markets. This collaboration merges portfolio data, valuation modeling, and reporting into a connected system within FactSet's Cobalt platform, addressing demands for more frequent, tran…
Nuwellis, Inc. announced its Q1 2026 financial results showing a 26% increase in net sales to $2.4 million and gross margin improvement to 70.1%. The company completed the acquisition of Rendiatech, enhancing its cardiorenal monitoring capabilities, secured new U.S. patents, and expanded commercial coverage. These developments mark progress in its …
JE Cleantech Holdings Ltd, a Singapore-based cleantech and precision cleaning equipment manufacturer listed on NASDAQ, announced improved financial performance for the fiscal year ended December 31, 2025. The company posted revenue of S$20.3 million, a net income increase to S$3.2 million from S$0.03 million in the prior year, and adjusted EBITDA d…
Corbus Pharmaceuticals announced Q1 2026 financial results with a net loss of $23 million, alongside significant clinical progress. The company reached broad FDA alignment on CRB-701 registration for second-line head and neck and cervical cancers and completed patient enrollment in the obesity treatment study for CRB-913, with topline data expected…
SPAR Group, Inc. reported first quarter fiscal 2026 results showing a 10% year-over-year revenue decline primarily due to reduced US Remodel business, but achieved higher gross margins at 22.3% and returned to positive EBITDA. The company strategically shifted its focus toward higher-margin recurring merchandising revenue, resulting in U.S. Merchan…
Apollo-managed funds have acquired a majority interest in Noble Environmental, a vertically integrated waste management company operating in the Northeast, Mid-Atlantic, and Midwest United States. The acquisition emphasizes Apollo's commitment to investing in essential service businesses with long-life hard assets and growth potential, including No…
SunPower Inc. reported preliminary unaudited Q1 2026 results with revenue of $72.8 million, a 9% decline from Q4 2025, and a non-GAAP operating loss of $12.9 million due to revenue shortfall and increased spending in anticipation of Q3 growth. The company completed its 2025 10K audit with required restatements of prior quarterly reports due to acco…
Rhythm Pharmaceuticals announced new data presentations highlighting the efficacy of its drug setmelanotide in treating acquired hypothalamic obesity (HO) and Bardet-Biedl syndrome (BBS). Real-world data from France demonstrated significant and sustained BMI reductions in adults with acquired HO over 12 months. Phase 3 analyses showed improvements …
Genius Group Limited (NYSE American: GNS), a leader in AI-powered education, announced strong Q1 2026 financial results with 171% revenue growth year-over-year, and detailed its strategic entry into regulated digital banking via a 9.9% equity stake in Jewel Bank, Bermuda's uniquely dual-licensed digital bank. The company plans to leverage this inve…
Humacyte, Inc., a Nasdaq-listed biotech company specializing in bioengineered human tissues, announced the appointment of Dr. Todd E. Rasmussen, a distinguished vascular surgeon, as Chief Surgical Officer. Dr. Rasmussen brings extensive clinical expertise and leadership to support the clinical use and adoption of Humacyte’s flagship product Symvess…
Daré Bioscience announced encouraging interim results from its ongoing Phase 3 clinical trial for Ovaprene®, a hormone-free, intravaginal monthly contraceptive. The Data Safety Monitoring Board recommended continuing the study without modification, confirming Ovaprene's safety profile and contraceptive efficacy consistent with company expectations.…
Rezolve Ai (NASDAQ: RZLV) announced a strategic global partnership with Tata Consultancy Services (TCS), a major IT services leader with $30bn+ revenue. Under the agreement, TCS will resell Rezolve's AI-powered commerce platform to its extensive enterprise client base, expanding Rezolve's global market reach and accelerating adoption of its AI-nati…
ABM Industries Incorporated, a leading provider of facility, engineering, and infrastructure solutions, announced it received the 2026 IABC Gold Quill Award of Excellence in recognition of its enterprise-wide brand transformation. The company has strategically repositioned itself from a commoditized service provider to a consultative partner delive…
Kalaris Therapeutics reported progress in its Phase 1b/2 clinical study of TH103 for neovascular age-related macular degeneration, with patient screening underway and new clinical material batches manufactured. Preliminary data is anticipated in the first half of 2027, and Phase 3 trials remain on track for year-end 2027 initiation. As of March 31,…
PMV Pharmaceuticals announced its first quarter 2026 financial results and key corporate updates, highlighting progress in the development of rezatapopt, a first-in-class p53 reactivator for TP53 Y220C mutated cancers. The company reported on-track enrollment in the registrational Phase 2 PYNNACLE study, upcoming NDA submission scheduled for early …
Eagle Bancorp, Inc., a prominent community bank holding company in the Washington, D.C. area, announced the appointment of Stephen Curley as president and CEO effective July 6, 2026. Curley brings over 25 years of banking experience and a strong track record in commercial banking, deposit growth, capital allocation, and risk management. The leaders…
